Diario Médico has reported on the progress made on cell therapy for the treatment of atrophic AMD. The research into this therapy enjoys the collaboration of the Barcelona Macula Foundation, the Centre of Regenerative Medicine of Barcelona, the Blood and Tissue Bank of Catalonia and the Leitat Technological Centre.
The project involves generating induced pluripotent stem cells and converting them into retinal pigment epithelium cells and photoreceptors. The aim is to apply this to animal models and humans in order to replace dead cells in affected retinas.
Atrophic AMD comprises 85% of all cases of Age-Related Macular Degeneration. While there is currently no treatment for the condition, highly intensive and encouraging research is being conducted worldwide.
You can read the full article here.